• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.

作者信息

Yeung Chi-Keung, Loong Florence, Kwong Yok-Lam

机构信息

Department of Medicine, Queen Mary Hospital, Hong Kong, China.

出版信息

Br J Haematol. 2012 May;157(4):411. doi: 10.1111/j.1365-2141.2012.09088.x. Epub 2012 Mar 19.

DOI:10.1111/j.1365-2141.2012.09088.x
PMID:22429092
Abstract
摘要

相似文献

1
Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.浆细胞肿瘤所致硬化性黏液水肿：硼替佐米、沙利度胺和地塞米松治疗后快速缓解
Br J Haematol. 2012 May;157(4):411. doi: 10.1111/j.1365-2141.2012.09088.x. Epub 2012 Mar 19.
2
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.硼替佐米联合地塞米松及后续沙利度胺治疗新诊断的多发性骨髓瘤：中国经验
Leuk Res. 2009 Dec;33(12):1615-8. doi: 10.1016/j.leukres.2009.04.006.
3
Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib.一名多发性骨髓瘤患者的硬化性黏液水肿和皮肤-神经综合征经地塞米松和硼替佐米有效治疗。
Am J Hematol. 2011 Oct;86(10):893-6. doi: 10.1002/ajh.22131.
4
Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait.
Clin Adv Hematol Oncol. 2005 Dec;3(12):916-7; discussion 918.
5
Treatment of multiple myeloma: 2009 update.多发性骨髓瘤的治疗：2009年更新
Prescrire Int. 2009 Dec;18(104):263-6.
6
Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?原发性浆细胞白血病对硼替佐米与地塞米松联合治疗的反应：特定细胞遗传学和免疫表型特征是否影响治疗结果？
Leuk Res. 2008 Jul;32(7):1153-6. doi: 10.1016/j.leukres.2007.11.010. Epub 2008 Feb 20.
7
Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.在肿瘤溶解综合征发生后，采用硼替佐米/沙利度胺/地塞米松联合疗法使多发性骨髓瘤迅速完全缓解。
Cancer Chemother Pharmacol. 2008 Jun;62(1):181-2. doi: 10.1007/s00280-007-0574-9. Epub 2007 Aug 31.
8
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.序贯长春新碱、阿霉素、地塞米松（VAD）方案联合硼替佐米、沙利度胺、地塞米松（VTD）方案诱导，大剂量化疗联合自体造血干细胞移植巩固治疗初治多发性骨髓瘤的Ⅱ期临床研究。
Ann Hematol. 2012 Feb;91(2):249-56. doi: 10.1007/s00277-011-1298-9. Epub 2011 Jul 26.
9
Novel agents for relapsed and/or refractory multiple myeloma.新型药物治疗复发和/或难治性多发性骨髓瘤。
Cancer J. 2009 Nov-Dec;15(6):485-93. doi: 10.1097/PPO.0b013e3181c51cba.
10
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.硼替佐米治疗多发性骨髓瘤的神经毒性：单中心经验及文献综述
Cancer. 2007 Sep 1;110(5):1042-9. doi: 10.1002/cncr.22921.

引用本文的文献

1
Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema.针对浆细胞的疗法可使重度或复发/难治性硬化性黏液水肿患者产生显著的临床反应且疗效持久。
J Eur Acad Dermatol Venereol. 2025 May;39(5):1011-1016. doi: 10.1111/jdv.20257. Epub 2024 Jul 31.
2
Dermato-neuro Syndrome after COVID-19 Vaccination in a Patient with Scleromyxoedema Previously Controlled with Bortezomib and Intravenous Immunoglobulins.1例曾用硼替佐米和静脉注射免疫球蛋白控制的硬化性黏液水肿患者接种新冠疫苗后出现皮肤神经综合征
Acta Derm Venereol. 2022 Dec 13;102:adv00836. doi: 10.2340/actadv.v102.4430.
3
Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment.
具有临床意义的单克隆丙种球蛋白病（MGCS）：追求最佳治疗。
Front Immunol. 2022 Nov 23;13:1045002. doi: 10.3389/fimmu.2022.1045002. eCollection 2022.
4
Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.与单克隆丙种球蛋白病相关的早期硬皮病性黏液水肿性阿恩特-戈特龙征：静脉注射免疫球蛋白治疗成功
Clin Case Rep. 2022 Aug 3;10(8):e6122. doi: 10.1002/ccr3.6122. eCollection 2022 Aug.
5
Cutaneous manifestations of monoclonal gammopathy.单克隆丙种球蛋白病的皮肤表现。
Blood Cancer J. 2022 Apr 11;12(4):58. doi: 10.1038/s41408-022-00661-1.
6
New insights on scleromyxedema.硬皮病性黏液水肿的新见解。
J Scleroderma Relat Disord. 2019 Jun;4(2):118-126. doi: 10.1177/2397198318824929. Epub 2019 Jan 29.
7
Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report.硬肿性黏液水肿并发多发性骨髓瘤致严重但可逆转的肺动脉高压：病例报告。
BMC Pulm Med. 2020 Jan 9;20(1):8. doi: 10.1186/s12890-019-1020-6.
8
Scleromyxedema, a therapeutic dilemma.硬化性黏液水肿，一种治疗难题。
Indian J Dermatol. 2015 Mar-Apr;60(2):215. doi: 10.4103/0019-5154.152600.
9
Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.硬肿性黏液水肿中特定的淋巴结受累：高代谢性淋巴结病的一个新的诊断实体。
Virchows Arch. 2013 Jun;462(6):679-83. doi: 10.1007/s00428-013-1424-2. Epub 2013 May 17.